These results support the role of SPL in sphingolipid pathway modulation in mouse colon cancer cell lysates with enhanced or inhibited SPL expression, demonstrating changes in S1P levels and corresponding alterations in other sphingolipids (Supplementary Fig. S4). Here, MBTPS1 is linked to colonic neoplasm.